The always phenomenal Outside The Box newsletter from John Mauldin features some good stuff by Patrick Cox of the Breakthrough Technology Alert this week. Mauldin introduces Cox by laying out a case for the next decade being primed for a biotech bubble, one in which brilliant new therapies and treatments will be introduced and big money will be both made and lost…
From Outside The Box:
I think there is a potential for another bubble over the next decade. There will probably be several, but there is one I am particularly interested in and that is biotech, with an emphasis on stem cell and gene therapy and their allied kin. For reasons outlined by my friend Patrick Cox, writer of the newsletter Breakthrough Technology Alert, in today’s Outside the Box, I think we are on the cusp of a decade of remarkable breakthroughs which will change the way we do medicine.
While some of these breakthroughs will come via large firms, others will be in smaller companies. Imagine cures for certain types of cancer. Rejuvenation of failing hearts? Livers? Genetic therapies for all types of diseases? The list of potential blockbuster therapies from current research is enormous and growing.
There are going to be some companies which will simply see their stocks explode. Of course, for everyone that has a large run, there will be failures which will go to zero. Or companies that seemingly have “the cure” only to have another company come along with something faster and cheaper, wrecking their share values. (Think of the dawn of the computer age and how many once high flying stocks went to zero. Biotech stocks are not bonds.)
But I think (personal belief here) that what will capture the imagination will be the large winners. Everyone will want to be in at the beginning of a new home run. As the decade goes along, we will see companies go public before they are really ready, just because they have a great story and people will want to fund that story.
It has the classic potential to become a bubble, because there is a deep reality – some substance to the stories of the winners – that will make people look for the next big winner. So far, we as humans have not proven ourselves able to resist bubbles. Maybe this will be the time we all become adults and there will be no bubble. Maybe. But my thought is that it will not be.
***
To read the whole thing, head over to John’s site and subscribe (free):
I’m a New York City-based financial advisor at Ritholtz Wealth Management LLC. I help people invest and manage portfolios for them. For disclosure information please see here.
Get a Full Investor Curriculum: Join The Book List
Every month you'll receive 3-4 book suggestions--chosen by hand from more than 1,000 books. You'll also receive an extensive curriculum (books, articles, papers, videos) in PDF form right away.
[…] The biotech boom/bubble is nigh. (Howard Lindzon, The Reformed Broker) […]
[…] The biotech boom/bubble is nigh. (Howard Lindzon, The Reformed Broker) […]
[…] The biotech boom/bubble is nigh. (Howard Lindzon, The Reformed Broker) […]
[…] The biotech boom/bubble is nigh. (Howard Lindzon, The Reformed Broker) […]
… [Trackback]
[…] Find More to that Topic: thereformedbroker.com/2010/01/12/john-mauldin-sees-a-biotech-bubble-and-wants-in/ […]
… [Trackback]
[…] Here you can find 30585 additional Info on that Topic: thereformedbroker.com/2010/01/12/john-mauldin-sees-a-biotech-bubble-and-wants-in/ […]
… [Trackback]
[…] Info to that Topic: thereformedbroker.com/2010/01/12/john-mauldin-sees-a-biotech-bubble-and-wants-in/ […]
… [Trackback]
[…] Info to that Topic: thereformedbroker.com/2010/01/12/john-mauldin-sees-a-biotech-bubble-and-wants-in/ […]
… [Trackback]
[…] Info on that Topic: thereformedbroker.com/2010/01/12/john-mauldin-sees-a-biotech-bubble-and-wants-in/ […]
… [Trackback]
[…] Find More Info here on that Topic: thereformedbroker.com/2010/01/12/john-mauldin-sees-a-biotech-bubble-and-wants-in/ […]
… [Trackback]
[…] There you can find 34569 more Information on that Topic: thereformedbroker.com/2010/01/12/john-mauldin-sees-a-biotech-bubble-and-wants-in/ […]
… [Trackback]
[…] Read More here on that Topic: thereformedbroker.com/2010/01/12/john-mauldin-sees-a-biotech-bubble-and-wants-in/ […]
… [Trackback]
[…] Information to that Topic: thereformedbroker.com/2010/01/12/john-mauldin-sees-a-biotech-bubble-and-wants-in/ […]